Manufacturer
GLAXO WELLCOME OPERATIONS
Contents
Betamethasone-17-valerate 0.1%, neomycin sulphate 0.5%
Indication
Relief of inflammatory & pruritic manifestations of steroid-responsive dermatoses eg, atopic, infantile & discoid eczemas, prurigo nodularis, psoriasis (excluding widespread plaque psoriasis), neurodermatoses including lichen simplex & planus, seborrheic dermatitis, contact sensitivity reactions, insect bites reactions. Management of secondary infected insect bites, anal & genital intertrigo.
Instruction
Apply thinly to affected area once or bd for up to 7 days.
Drug interaction
Inhibited metabolism by CYP3A4 inhibitors eg, ritonavir, itraconazole. Intensified & prolonged resp depressant effects of neuromuscular blocking agents. Possibility of cumulative toxicity w/ systemic aminoglycoside therapy.
Malaysia
